Down-regulation of DNMT3b in PC3 cells effects locus-specific DNA methylation, and represses cellular growth and migration.
BACKGROUND
Aberrations in DNA methylation patterns promote changes in gene expression patterns and are invariably associated with neoplasia. DNA methylation is carried out and maintained by several DNA methyltransferases (DNMTs) among which DNMT1 functions as a maintenance methylase while DNMT3a and 3b serve as de novo enzymes. Although DNMT3b has been shown to preferentially target the methylation of DNA sequences residing in pericentric heterochromatin whether it is involved in gene specific methylation remains an open question. To address this issue, we have silenced the expression of DNMT3b in the prostate-derived PC3 cells through RNA interference and subsequently studied the accompanied cellular changes as well as the expression profiles of selected genes.


RESULTS
Our results demonstrate that DNMT3b depletion results in increased apoptosis and reduced migration of PC3 cells compared to the untransfected control cells. Reduced DNMT3b expression resulted in hypomethylation of retinoblastoma (Rb), retinoic-acid receptor beta (RAR-beta), and adenomatous polyposis coli (APC) gene promoters, and also culminated in increased expression of CDKN3 and cytochrome b5. Although DNMT3b silenced cells were found to have reduced growth and migratory potential, there was no apparent changes in their invasive ability compared to the parental PC3 cell line.


CONCLUSIONS
Our findings reveal that DNMT3b preferentially targets certain gene promoters in PC3 cells and that its depletion significantly reduces growth and migration of PC3 cells.
Yaqinuddin
Ahmed
A
Department of Biological & Biomedical Sciences, The Aga Khan University, Stadium Road, Karachi 74800, Pakistan. ahmed.yaqin@aku.edu
Qureshi
Sohail A
SA
Qazi
Romena
R
Abbas
Farhat
F
Int J Dev Biol. 2004;48(5-6):563-71
15349831
Nat Rev Genet. 2002 Jun;3(6):415-28
12042769
Biochemistry (Mosc). 2005 Jul;70(7):730-42
16097936
Gene. 1999 Aug 5;236(1):87-95
10433969
Trends Genet. 2000 Apr;16(4):168-74
10729832
Oncogene. 2002 Oct 3;21(44):6835-40
12360410
Cancer. 2006 Sep 1;107(5):1042-9
16888795
Blood. 2001 Mar 1;97(5):1172-9
11222358
Clin Cancer Res. 2006 Sep 1;12(17):5040-6
16951219
Int J Colorectal Dis. 2007 Jun;22(6):661-6
17093909
Hepatology. 2001 Mar;33(3):561-8
11230735
Curr Top Microbiol Immunol. 2006;301:203-25
16570849
Oncol Rep. 2006 Mar;15(3):615-20
16465421
Mol Cell Biol. 2003 Aug;23(16):5594-605
12897133
J Thorac Cardiovasc Surg. 2006 Feb;131(2):298-306
16434257
Nature. 2002 Apr 4;416(6880):552-6
11932749
Biol Pharm Bull. 2005 Apr;28(4):740-3
15802821
Int J Cancer. 2001 Jan 15;91(2):205-12
11146446
Nucleic Acids Res. 1999 Jun 1;27(11):2291-8
10325416
J Biol Chem. 2002 Aug 2;277(31):28176-81
12015329
Science. 2007 Sep 21;317(5845):1760-4
17673620